Back to Search
Start Over
Table 1.Detailed description of dose and schedule developed and toxicity reported in phase I and registration trials for each SM-MTA. from Are Doses and Schedules of Small-Molecule Targeted Anticancer Drugs Recommended by Phase I Studies Realistic?
Table 1.Detailed description of dose and schedule developed and toxicity reported in phase I and registration trials for each SM-MTA. from Are Doses and Schedules of Small-Molecule Targeted Anticancer Drugs Recommended by Phase I Studies Realistic?
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Detailed description of phase I and registration trials for each approved small molecule. Dose and schedule developed will be specified, along with dose modifications due to toxicity.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....d9c975b03dd6ebb9570162bbb9115e56
- Full Text :
- https://doi.org/10.1158/1078-0432.22456578